Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Li, Yu ^a   Xu, Shanqin ^a   Jiang, Bingbing ^a   Cohen, Richard A ^a   Zang, Mengwei ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; APOPTOSIS ASSOCIATED SPECK LIKE PROTEIN; CHOLESTEROL; CRYOPYRIN; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMASOME; INTERLEUKIN 1BETA; LIPID; SERINE; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL BIOPSY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME REPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID STORAGE; MACROPHAGE; MALE; NONHUMAN; PATHOGENESIS; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SWINE; VASCULITIS;

ACETYLATION; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AORTA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMASOMES; INTERLEUKIN-1BETA; MALE; MICE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEOLYSIS; SERINE; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; SWINE; VASCULAR CELL ADHESION MOLECULE-1;

ANIMALIA; MUS; SUIDAE; SUS;

EID: 84879337071     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067532     Document Type: Article

References (44)

1. Libby P, Ridker PM, Hansson GK, (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473: 317-325.
2. Bornfeldt KE, Tabas I, (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism 14: 575-585.
3. Goldstein JL, Brown MS, (2008) From fatty streak to fatty liver: 33 years of joint publications in the JCI. Journal of Clinical Investigation 118: 1220-1222.
4. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB, (2008) SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends in Endocrinology and Metabolism 19: 65-73.
5. Horton JD, Goldstein JL, Brown MS, (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation 109: 1125-1131.
6. Li Y, Xu SQ, Mihaylova MM, Zheng B, Hou XY, et al. (2011) AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice. Cell Metabolism 13: 376-388.
7. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, et al. (2010) NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-13U7.
8. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, et al. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine 17: 179-U214.
9. Schroder K, Tschopp J, (2010) The Inflammasomes. Cell 140: 821-832.
10. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, et al. (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proceedings of the National Academy of Sciences of the United States of America 106: 20388-20393.
11. Im SS, Yousef L, Blaschitz C, Liu JZ, Edwards RA, et al. (2011) Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1a. Cell Metabolism 13: 540-549.
12. Jawien J, Nastalek P, Korbut R, (2004) Mouse models of experimental atherosclerosis. Journal of Physiology and Pharmacology 55: 503-517.
13. Gerrity RG, Natarajan R, Nadler JL, Kimsey T, (2001) Diabetes-induced accelerated atherosclerosis in swine. Diabetes 50: 1654-1665.
14. Xu S, Ying J, Jiang B, Guo W, Adachi T, et al. (2006) Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol 290: H2220-H2227.
15. Li Y, Xu SQ, Giles A, Nakamura K, Lee JW, et al. (2011) Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. Faseb Journal 25: 1664-1679.
16. Zuccollo A, Shi CM, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, et al. (2005) The thromboxane A(2) receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus. Circulation 112: 3001-3008.
17. Gerrity RG, Naito HK, Richardson M, Schwartz CJ, (1979) Dietary Induced Atherogenesis in Swine- Morphology of the Intima in Pre-Lesion Stages. American Journal of Pathology 95: 775.
18. Ying J, Sharov V, Xu SQ, Jiang BB, Gerrity R, et al. (2008) Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca(2+) ATPase in diabetic pig aorta. Free Radical Biology and Medicine 45: 756-762.
19. Zang MW, Xu SQ, Maitland-Toolan KA, Zuccollo A, Hou XY, et al. (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55: 2180-2191.
20. Zang MW, Zuccollo A, Hou XY, Nagata D, Walsh K, et al. (2004) AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. Journal of Biological Chemistry 279: 47898-47905.
21. Libby P, Theroux P, (2005) Pathophysiology of coronary artery disease. Circulation 111: 3481-3488.
22. Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, et al. (1999) ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Molecular and Cellular Biology 19: 3760-3768.
23. Vaziri H, Dessain SK, Eagon EN, Imai SI, Frye RA, et al. (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
24. Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, et al. (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A 100: 10794-10799.
25. Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, et al. (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metabolism 2: 67-76.
26. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, et al. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191-196.
27. Luo J, Nikolaev AY, Imai S, Chen D, Su F, et al. (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
28. Luo JY, Su F, Chen DL, Shiloh A, Gu W, (2000) Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 408: 377-381.
29. Yin HQ, Ajmo JM, Murr M, You M, (2012) Mir-217 is a Major Inflammatory Regulator in Experimental Alcoholic Steatohepatitis. Hepatology 56: 1119A.
30. Xu S, Jiang B, Hou X, Shi C, Bachschmid MM, et al. (2011) High-fat diet increases and the polyphenol, S17834, decreases acetylation of the sirtuin-1-dependent lysine-382 on p53 and apoptotic signaling in atherosclerotic lesion-prone aortic endothelium of normal mice. J Cardiovasc Pharmacol 58: 263-271 10.1097/FJC.0b013e3182239eb7 [doi].
31. Ponugoti B, Kim DH, Xiao Z, Smith Z, Miao J, et al. (2010) SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism. Journal of Biological Chemistry 285: 33959-33970.
32. Walker AK, Yang FJ, Jiang KR, Ji JY, Watts JL, et al. (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes & Development 24: 1403-1417.
33. You M, Liang XM, Ajmo JM, Ness GC, (2008) Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 294: G892-G898.
34. Hansson GK, (2005) Inflammation, atherosclerosis, and coronary artery disease- Reply. New England Journal of Medicine 353: 429-430.
35. Goldin A, Beckman JA, Schmidt AM, Creager MA, (2006) Advanced glycation end products- Sparking the development of diabetic vascular injury. Circulation 114: 597-605.
36. Stein S, Matter CM, (2011) Protective roles of SIRT1 in atherosclerosis. Cell Cycle 10: 640-647.
37. Towler MC, Hardie DG, (2007) AMP-activated protein kinase in metabolic control and insulin signaling. Circulation Research 100: 328-341.
38. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, et al. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovascular Research 80: 191-199.
39. Dong YZ, Zhang M, Liang B, Xie ZL, Zhao ZX, et al. (2010) Reduction of AMP-Activated Protein Kinase alpha 2 Increases Endoplasmic Reticulum Stress and Atherosclerosis In Vivo. Circulation 121: 792-803.
40. Hou X, Xu S, Maitland-Toolan KA, Sato K, Jiang B, et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283: 20015-20026.
41. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, et al. (2012) SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function. Cell Metab 15: 675-690 S1550-4131(12)00143-X [pii];10.1016/j.cmet.2012.04.003 [doi].
42. Lin T, Zeng LF, Liu Y, Defea K, Schwartz MA, et al. (2003) Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circulation Research 92: 1296-1304.
43. Yeh M, Cole AL, Choi J, Liu Y, Tulchinsky D, et al. (2004) Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circulation Research 95: 780-788.
44. Lan F, Cacicedo JM, Ruderman N, Ido Y, (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283: 27628-27635.